Table 4. Associations between oxyntomodulin and cholecystokinin, vasoactive intestinal peptide, and secretin.
| Glucoregulatory peptide model |
Oxyntomodulin |
||
|---|---|---|---|
| β (95% CI) | P value | R2 | |
| Model 1 | 0.442 | ||
| Cholecystokinin | 11.34 (3.97, 18.71) | 0.003 | |
| VIP | 26.11 (14.01, 38.20) | <0.001 | |
| Model 2 | 0.384 | ||
| Cholecystokinin | 13.66 (5.95, 21.38) | 0.001 | |
| Secretin | 25.40 (8.72, 42.07) | 0.003 | |
| Model 3 | 0.427 | ||
| Secretin | 21.56 (5.39, 37.73) | 0.010 | |
| VIP | 26.68 (14.72, 38.64) | <0.001 | |
| Model 4 | 0.459 | ||
| Cholecystokinin | 9.61 (1.94, 17.28) | 0.015 | |
| Secretin | 12.99 (−4.50, 30.49) | 0.143 | |
| VIP | 21.99 (8.78, 35.20) | 0.001 | |
VIP, vasoactive intestinal peptide. All data are presented as β coefficient (95% CI). For oxyntomodulin, Model 1 was adjusted for cholecystokinin and VIP; Model 2 was adjusted for cholecystokinin and secretin; Model 3 was adjusted for VIP and secretin; and Model 4 was adjusted for cholecystokinin, VIP, and secretin. Significant (P<0.05) associations are shown in bold.